By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Valerion Therapeutics, LLC 

100 Main Street
Suite 110
Concord  Massachusetts  01742  U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS

Valerion Therapeutics (www.valerion.com) is a biotechnology company focused on developing therapies for orphan genetic diseases utilizing a proprietary antibody-mediated delivery platform to target specific tissues.

This platform is capable of enhanced intracellular delivery of a variety of active therapeutic molecules via a well-known and broadly studied transport mechanism that is present in muscles and neurons. Pipeline candidates include therapies aimed at addressing orphan genetic disorders with limited or no current therapies. Valerion Therapeutics is part of the Alopexx Enterprises portfolio of companies (www.alopexx.com).

YEAR FOUNDED:

2007

LEADERSHIP:

CEO: Deborah Ramsdell

CSO: Dustin Armstrong

CMO: Hal Landy

CLINICAL TRIAL:

Please click here for clinical trial information.


Key Statistics


Email:
Ownership: Private

Web Site: Valerion Therapeutics, LLC
Employees:
Symbol: 
 



Industry
Biotechnology






Company News
//-->